Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groupsHeba Alshaker, Dmitri Pchejetski, Robert Mills et al.|Journal of Translational Medicine|2021Cited by 22
Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profilingEwan Hunter, Dmitri Pchejetski, Heba Alshaker et al.|Journal of Translational Medicine|2025Cited by 14
Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological IndicationsEwan Hunter, Alexandre Akoulitchev, Mutaz Issa et al.|Cancers|2023Cited by 14
Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer DetectionDmitri Pchejetski, Mathias Winkler, Ewan Hunter et al.|Cancers|2023Cited by 13
Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cellsHeba Alshaker, Dmitri Pchejetski, Ewan Hunter et al.|Frontiers in Oncology|2022Cited by 6